overall survival

You have access
Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept
YUNAMI YAMADA, NOBUHISA MATSUHASHI, HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, TAKAO TAKAHASHI, DAICHI WATANABE, SHIGERU KIYAMA, RYO KOBAYASHI, AKIO SUZUKI and KAZUHIRO YOSHIDA

Anticancer Research January 2021, 41 (1) 533-541; DOI: https://doi.org/10.21873/anticanres.14805
You have access
Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer
HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, NAOKI OKUMURA, SENRI YAMAMOTO, TAKEHARU IMAI, SHINICHIRO ARAKAWA, RYO KOBAYASHI, YOSHIHIRO TANAKA, KAZUHIRO YOSHIDA and AKIO SUZUKI

Anticancer Research December 2020, 40 (12) 7067-7075; DOI: https://doi.org/10.21873/anticanres.14734
You have access
Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI and TOMOAKI YOSHIMURA

Anticancer Research December 2020, 40 (12) 7135-7140; DOI: https://doi.org/10.21873/anticanres.14743
You have access
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin
ATSUSHI SATA, REIKO FUKUI, YOSHIMASA MIYAGAWA, AYAKO BUN, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, MICHIKO IMAMURA and YASUO MIYOSHI

Anticancer Research July 2020, 40 (7) 4147-4156; DOI: https://doi.org/10.21873/anticanres.14414
You have access
Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms
HITOSHI HIRAKAWA, TARO IKEGAMI, SATOE AZECHI, SHINYA AGENA, JIN UEZATO, HIDETOSHI KINJYO, YUKASHI YAMASHITA, ASANORI KIYUNA, KATSUNORI TANAKA, SHUNSUKE KONDO, HIROYUKI MAEDA, MIKIO SUZUKI and AKIRA GANAHA

Anticancer Research June 2020, 40 (6) 3277-3285; DOI: https://doi.org/10.21873/anticanres.14310
You have access
Extra-cerebral Metastasis – An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT)
DIRK RADES, TRANG NGUYEN and STEVEN E. SCHILD

Anticancer Research May 2020, 40 (5) 2841-2845; DOI: https://doi.org/10.21873/anticanres.14258
You have access
Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis
NOBUHIDE HIGASHINO, TAKERU MATSUDA, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, HIROKI SAKAMOTO, MASATAKA FUJIKAWA, MASASHI YAMAMOTO, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI and YOSHIHIRO KAKEJI

Anticancer Research April 2020, 40 (4) 2165-2170; DOI: https://doi.org/10.21873/anticanres.14176
You have access
Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer
HIROSHI TAMAGAWA, TORU AOYAMA, AYAKO TAMAGAWA, KEISUKE KOMORI, YUKIO MAEZAWA, KAZUKI KANO, MASAAKI MURAKAWA, YOSUKE ATSUMI, KENTARO HARA, KEISUKE KAZAMA, MASAKATSU NUMATA, TAKASHI OSHIMA, NORIO YUKAWA, MUNETAKA MASUDA and YASUSHI RINO

Anticancer Research April 2020, 40 (4) 2365-2371; DOI: https://doi.org/10.21873/anticanres.14205
You have access
Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA

Anticancer Research March 2020, 40 (3) 1605-1611; DOI: https://doi.org/10.21873/anticanres.14108
You have access
Impact of Anastomotic Leakage on Overall and Disease-free Survival After Surgery for Gastric Carcinoma: A Systematic Review
PAOLO AURELLO, MATTEO CINQUEPALMI, NICCOLÒ PETRUCCIANI, GIOVANNI MOSCHETTA, LAURA ANTOLINO, FEDERICA FELLI, DIEGO GIULITTI, GIUSEPPE NIGRI, FRANCESCO D'ANGELO, STEFANO VALABREGA and GIOVANNI RAMACCIATO

Anticancer Research February 2020, 40 (2) 619-624; DOI: https://doi.org/10.21873/anticanres.13991

Main menu

User menu

Search

overall survival

Pages